Primary record
3-(4-methylsulfonylphenyl)-4-(2,3,4,5,6-pentadeuteriophenyl)-2H-furan-5-one
- 库存
- 6,193 克
- 纯度
- 98.1 %
- CAS
- 162011-90-7
化合物标识与属性
- CAS
- 162011-90-7
- PubChem CID
- 5090
- SMILES
- CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
- Canonical SMILES
- CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1
名称与同义词
- rofecoxib
- Vioxx
- Ceoxx
- 162011-90-7
- refecoxib
- Vioxx Dolor
- ceeoxx
- rofecoxibum
- Romacox
- Rhuma-cure
- Vioxx (trademark)
- Rofecoxib-d5
- Ceoxx;
- Vioxx;
- MK 966
- Vioxx (TN)
- Rofecoxib (Vioxx)
- Rofecoxib [USAN]
- Ceeoxx (TN)
- MK-966
- 0QTW8Z7MCR
- Vioxx-d5 (Major)
- Ceoxx (TN)
- Rofecoxib (Standard)
- UNII-0QTW8Z7MCR
- MK0966
- MSD brand of rofecoxib
- Spectrum_000119
- 4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one
- MK-0966
- CHEMBL122
- RefChem:55985
- ROFECOXIB [INN]
- ROFECOXIB [JAN]
- SpecPlus_000669
- Merck brand of rofecoxib
- ROFECOXIB [MI]
- C17H14O4S
- ROFECOXIB [HSDB]
- Spectrum2_000446
- Spectrum3_001153
- Spectrum4_000631
- Spectrum5_001598
- TRM-201
- CCRIS 8967
- CHEBI:8887
- ROFECOXIB [VANDF]
- TRM201
- DTXSID2023567
- MFCD00935806
- MK 0966
- Rofecoxib (JAN/USAN/INN)
- Rofecoxib [USAN:INN:BAN]
- D05VLS
- Epitope ID:613455
- ROFECOXIB [MART.]
- HSDB 7262
- AC1L1JL6
- M01AH02
- ROFECOXIB [WHO-DD]
- SCHEMBL3050
- DTXCID903567
- RZJQGNCSTQAWON-UHFFFAOYSA-N
- 4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
- MK966
- BSPBio_002705
- KBioGR_001242
- KBioGR_002345
- KBioSS_000559
- KBioSS_002348
- 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
- MLS000759440
- MLS001165770
- MLS001195623
- MLS001424113
- MLS006010091
- BIDD:GT0399
- DivK1c_006765
- Merck Frosst brandof rofecoxib
- NSC-720256
- NSC-758705
- SPECTRUM1504235
- Rofecoxib - Bio-X trade mark
- SPBio_000492
- MK 996
- GTPL2893
- orb1309482
- ZINC7455
- Jsp003237
- ROFECOXIB [ORANGE BOOK]
- BDBM22369
- ERK5-3C14
- KBio1_001709
- KBio2_000559
- KBio2_002345
- KBio2_003127
- KBio2_004913
- KBio2_005695
- KBio2_007481
- KBio3_002205
- KBio3_002825
- KS-00000XKS
- AOB6956
- CID5090
- EX-A708
- cMAP_000024
- NSC720256
- 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
- GLXC-05865
- HMS1922H11
- HMS2051G16
- HMS2089H20
- HMS2093E04
- HMS2232G21
- HMS3371P11
- HMS3393G16
- HMS3651F16
- HMS3713B07
- HMS3750I17
- HMS3885E05
- HMS5081K08
- Pharmakon1600-01504235
- BCP03619
- CID:5090
- EBD34785
- KS-1107
- MK 0996
- MSK10084
- UWA68493
- Tox21_111430
- 2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-
- ANW-71936
- C17-H14-O4-S
- CCG-40253
- EBC-17057
- HY-17372R
- NCGC00095118-01
- NSC758705
- s3043
- STK635144
- Cahill May Roberts brand of rofecoxib
- AKOS000280931
- AB07701
- CS-0997
- CS-O-02291
- DB00533
- FV28711
- NC00132
- NSC 720256
- NSC 758705
- SB19518
- VA11689
- 3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone
- 4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
- 4-(4-methanesulfonylphenyl)-3-phenyl-2,5-dihydrofuran-2-one
- Merck Sharp & Dhome brand of rofecoxib
- 4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one
- NCGC00095118-02
- NCGC00095118-03
- NCGC00095118-04
- NCGC00095118-05
- NCGC00095118-08
- NCGC00095118-17
- NCGC00095118-18
- AC-28318
- AJ-08299
- AK-60971
- AN-25306
- BR164362
- CPD000466331
- HY-17372
- LS-70511
- NCI60_041175
- SAM001246617
- SC-17320
- SID:53790447
- SMR000466331
- SY235207
- ZB000656
- 4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
- SBI-0206774.P001
- 3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone
- AB0012045
- RT-016235
- ST2410970
- B1454
- CAS-162011-90-7
- FT-0631192
- NS00003940
- R0206
- SW219668-1
- J1.041.252H
- A11918
- C07590
- D00568
- J10420
- K-5064
- 3-(4-methanesulfonylphenyl)-2-phenyl-2-buten-4-olide
- AB00052090-06
- AB00052090-08
- AB00052090_09
- AB00052090_10
- EN300-7364304
- 011R907
- A810324
- C116926
- L000912
- Q411412
- SR-01000762904
- 2(5H)-Furanone, 4-(4-(methylsulfonyl)phenyl)-3-phenyl-
- 3-(4-Metanesulfonilfenil)-2-fenil-2-buten-4-olide
- I01-1042
- SR-01000762904-3
- SR-01000762904-5
- 3-phenyl-4-(4-methylsulfonylphenyl)-2(5h)-furanone
- BRD-K21733600-001-02-6
- BRD-K21733600-001-06-7
- BRD-K21733600-001-14-1
- BRD-K21733600-001-15-8
- BRD-K21733600-001-19-0
- BRD-K21733600-001-23-2
- BRD-K21733600-001-24-0
- 2(5H)-furanona, 4-[4-(metilsulfonil) fenil]-3-fenil-
- 3-(4-methanesulfonyl-phenyl)-2-phenyl-2-buten-4-olide
- 3-phenyl-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone
- 3-Phenyl-4-[4-(methylsulfonyl)phenyl]furan-2(5H)-one
- 4-(4'-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
- 4-(4-(Methanesulfonyl)phenyl)-3-phenyl-5H-furan-2-one
- 4-[(4-Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
- 4-[4-(Methanesulfonyl)phenyl]-3-phenylfuran-2(5H)-one
- Z2037279770
- 2(5H)-Furanone, 4-[4-(methyl-sulfonyl)phenyl]-3-phenyl-
- 3-(Phenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone
- 3-Phenyl-4-(4-(Methylsulfonyl)Phenyl)-2-(5H)-Furanone
- 3-Phenyl-4-[4-(methylsulfonyl)phenyl]-2,5-dihydrofuran-2-one
- 4-(4-METHANESULFONYL-PHENYL)-3-PHENYL-5H-FURAN-2-ONE
- 4-(4-methylsulfonylphenyl)-3-phenyl-2,5-dihydro-2-furanone
- Vioxx; 4-[4-(Methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
- 544684-93-7
- 3-(4-methylsulfonylphenyl)-4-(2,3,4,5,6-pentadeuteriophenyl)-2H-furan-5-one
- 803-260-0
- N/A